Health Cingulate Announces Positive Top-Line Results from Phase 3 Adult Efficacy and Safety Trial of… James Pereira Jul 11, 2023 KANSAS CITY, Kan., July 11, 2023 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company… Read More...
Health Cingulate Inc. Reports First Quarter 2023 Financial Results and Provides Clinical and Business… James Pereira May 11, 2023 <!-- Name:DistributionId Value:8836312 --> <!--… Read More...
Health Cingulate and Indegene Announce Joint Commercialization Agreement for Lead ADHD Candidate CTx-1301 James Pereira Mar 13, 2023 <!-- Name:DistributionId Value:8786516 --> <!--… Read More...
Health Cingulate Announces Positive Top-Line Results from Fed/Fast Study of Lead Asset CTx-1301 for ADHD James Pereira Feb 24, 2023 <!-- Name:DistributionId Value:8755907 --> <!--… Read More...
Health Cingulate Completes Fed/Fast Study Assessing Food Effect with CTx-1301, Lead Candidate for Treatment… James Pereira Nov 1, 2022 KANSAS CITY, Kan., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company… Read More...
Business Cingulate Announces Agreement with Societal CDMO and Provides Clinical Update Nick J Adam Oct 25, 2022 KANSAS CITY, Kan., Oct. 24, 2022 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company… Read More...
Health Cingulate Presents Data for Its Triple-Release Buspirone Product Candidate: CTx-2103 James Pereira Sep 19, 2022 Data Demonstrated Ability of CTx-2103 to Deliver a Single Administration of Triple-Release Buspirone – Setting the… Read More...
Health Cingulate to Participate in Benzinga All Live Access Event James Pereira Aug 16, 2022 KANSAS CITY, Kan., Aug. 15, 2022 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a clinical-stage… Read More...
Gaming WoW Cross-Faction Guilds Are Possible Thanks To A PTR Glitch, But Don’t Expect It To Become… Kemal Pasha May 25, 2022 When Blizzard announced World of Warcraft would get cross-faction support in the upcoming patch 9.2.5,… Read More...
Health Cingulate to Present at H.C. Wainwright Global Investment Conference James Pereira May 19, 2022 KANSAS CITY, Kan., May 18, 2022 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a clinical-stage biopharmaceutical… Read More...